Press Releases

Bethesda, Md. - The Parenteral Drug Association announced the results of its 2014 Board of Directors and Officers Elections. All those elected begin their terms in January 2014

Bethesda, Md. - Producing sterile products using aseptic processing technology is challenging and the FDA is aware of these challenges. Therefore the agency places a major emphasis on this area as part of its oversight responsibility.

Bethesda, Md. – 45 pharmaceutical professionals have formed the Singapore chapter of PDA, bringing to 24 the number of chapters across the globe.

Bethesda, Md. – Many of the nearly 1,000 people who attended the 23rd Annual PDA/FDA Joint Regulatory Conference said the event provided them the opportunity to hear directly from regulators on the issues that affect them most, and from industry experts on how they are responding to these same issues.

Bethesda, Md., For government regulators across the globe, the Parenteral Drug Association is offering free or greatly reduced electronic membership fees.

Bethesda, Md., When the topic of single use systems comes up among pharmaceutical manufacturers, there seems to be more questions than answers.

Bethesda, Md., For members of the Parenteral Drug Association, this is election season – for open seats on the 2014 Board of Directors.

Although Polymer as a container material for medicinal products has been accepted as an alternative to glass in certain regions and many applications, it is still not always seen as a first choice alternative for pre-filled syringes. However, development and acceptance of polymer as a packaging material has come a long way. Ten years ago, polymer was merely an exotic material for pre-filled syringes. Even though it was already well accepted e. g. in flexible bags (LVP) then, its use in prefilled syringe applications did not attract much attention.

NORWALK, CT, Aug. 19, 2013 – International Pharmaceutical Expo (INTERPHEX), the leading annual trade event dedicated to the pharmaceutical and biopharmaceutical industry and the Parenteral Drug Association (PDA) are pleased to announce a three-year Sponsorship Agreement.

PDA announced today that Richard Friedman, Associate Director OMPQ, U.S. FDA, and Rebecca Rodriguez, Consumer Safety Officer, U.S. FDA, have been confirmed to deliver the closing plenary talks at the 2013 Human Factors and Human Error Reduction Workshop.

Bethesda, Md., February 1, 2012 – The Parenteral Drug Association (PDA) is proud to announce the founding of the PDA Texas Chapter, which will serve PDA members in that area.

Bethesda, Md., January 7, 2013 – The Parenteral Drug Association (PDA) is proud to announce the establishment of the Martin VanTrieste Pharmaceutical Science Award.